EX-10.18
from F-4
15 pages
Sponsor Support Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”), Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), and Voyager Acquisition Sponsor Holdco LLC, a Delaware Limited Liability Company (“Sponsor”)
12/34/56
EX-10.17
from F-4
13 pages
Voting, Support and Lock-Up Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”) and the Persons Listed on Schedule a Hereto (Each, a “Shareholder” and Collectively, the “Shareholders”)
12/34/56
EX-10.18
from F-4
15 pages
Sponsor Support Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”), Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), and Voyager Acquisition Sponsor Holdco LLC, a Delaware Limited Liability Company (“Sponsor”)
12/34/56
EX-10.17
from F-4
13 pages
Voting, Support and Lock-Up Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”) and the Persons Listed on Schedule a Hereto (Each, a “Shareholder” and Collectively, the “Shareholders”)
12/34/56
EX-10.2
from 425
15 pages
Sponsor Support Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”), Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), and Voyager Acquisition Sponsor Holdco LLC, a Delaware Limited Liability Company (“Sponsor”)
12/34/56
EX-10.2
from 8-K
15 pages
Sponsor Support Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”), Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), and Voyager Acquisition Sponsor Holdco LLC, a Delaware Limited Liability Company (“Sponsor”)
12/34/56
EX-10.1
from 425
13 pages
Voting, Support and Lock-Up Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”) and the Persons Listed on Schedule a Hereto (Each, a “Shareholder” and Collectively, the “Shareholders”)
12/34/56
EX-10.1
from 8-K
13 pages
Voting, Support and Lock-Up Agreement, Dated as of April 22, 2025 (This “Agreement”), Among Voyager Acquisition Corp., an Exempted Company Limited by Shares Incorporated Under the Laws of the Cayman Islands (“Spac”), Veraxa Biotech AG, a Swiss Stock Corporation (Aktiengesellschaft) (The “Company”) and the Persons Listed on Schedule a Hereto (Each, a “Shareholder” and Collectively, the “Shareholders”)
12/34/56